Ipca Laboratories (NSE:IPCALAB) Common Stock: ₹254 Mil (As of Mar. 2026)


NSE:IPCALAB Ipca Laboratories Ltd NSE:IPCALAB
88 GF Score
Price ₹1,782.40
GF Value ₹1,600.36
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Ipca Laboratories Common Stock?

Ipca Laboratories NSE:IPCALAB +0.20% 88 Common Stock is ₹254 Mil as of Mar. 2026. GuruFocus rates NSE:IPCALAB with a GF Score™ of 88/100 and a GF Value™ of ₹1,600.36 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Ipca Laboratories's quarterly common stock declined from Sep. 2025 (₹254 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹254 Mil).

Ipca Laboratories's annual common stock stayed the same from Mar. 2024 (₹254 Mil) to Mar. 2025 (₹254 Mil) and stayed the same from Mar. 2025 (₹254 Mil) to Mar. 2026 (₹254 Mil).

Ipca Laboratories Common Stock Historical Data

* Premium members only.

The historical data trend for Ipca Laboratories's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ipca Laboratories Common Stock Chart

Ipca Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 253.70 253.70 253.70 253.70 253.70

Ipca Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 253.70 0.00 253.70 0.00 253.70
NSE:IPCALAB
88GF Score
Ipca Laboratories Ltd NSE:IPCALAB
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ipca Laboratories Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of ₹254 Mil mean?
Ipca Laboratories (NSE:IPCALAB) has a Common Stock of ₹254 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Ipca Laboratories and its competitors.
Is Ipca Laboratories' Common Stock too high?
Ipca Laboratories' current Common Stock is ₹254 Mil. Overall, Ipca Laboratories has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ipca Laboratories' Common Stock compare to ZTS and UTHR?
Ipca Laboratories' Common Stock of ₹254 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Ipca Laboratories and its competitors. Ipca Laboratories's current Common Stock is ₹254 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ipca Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Ipca Laboratories (NSE:IPCALAB) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,600.36, compared to a current price of ₹1,782.40 — trading 11.4% above its estimated fair value. The current Common Stock is ₹254 Mil. Ipca Laboratories' overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Ipca Laboratories (NSE:IPCALAB), the current Common Stock is ₹254 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ipca Laboratories (NSE:IPCALAB) Overvalued in 2026?

Based on GuruFocus' analysis, Ipca Laboratories stock appears to be overvalued. The current stock price of ₹1,782.40 is trading 11.4% above its estimated GF Value™ of ₹1,600.36. GuruFocus considers Ipca Laboratories to be Modestly Overvalued.

Key valuation signals for NSE:IPCALAB:

  • Common Stock: ₹254 Mil
  • GF Value™: ₹1,600.36 vs. price of ₹1,782.40 (11.4% above fair value)
  • GF Score™: 88/100 with 5 warning signs

No single metric tells the full story. See the NSE:IPCALAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ipca Laboratories Business Description

Other Exchanges 524494:India
Address No. 48, 123 AB, 125 & 126 Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Ipca Laboratories Ltd is a pharmaceutical company. The company's principal activity is the Development, Manufacturing, and Marketing of Pharmaceuticals Products. The company's API products include Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Chlorthalidone (diuretic), Furosemide (diuretic), Hydroxychloroquine Sulphate (DMARD), Losartan. The company has only one reportable primary business segment, pharmaceuticals.
88GF Score

Get the complete analysis for NSE:IPCALAB

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,782.40
Price
₹1,600.36
GF Value